Home › Funds › Bain Capital Life Sciences Investors, LLC › XFOR
Bain Capital Life Sciences Investors, LLC position in XFOR
X4 PHARMACEUTICALS INC · Health Care
Bain Capital Life Sciences Investors, LLC reported holding 7,967,454 shares of XFOR (X4 PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$23.1M, representing 1.59% of its reported portfolio and ranking #15 among its reported holdings. Bain Capital Life Sciences Investors, LLC has disclosed XFOR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Bain Capital Life Sciences Investors, LLC's XFOR position evolved
Bain Capital Life Sciences Investors, LLC first disclosed a stake in XFOR in Q3 2023 at 15,960,588 shares (US$17.4M). The position peaked in Q2 2026 at 7,967,454 shares, worth US$37.2M. Across 13 filings, Bain Capital Life Sciences Investors, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 7,967,454 shares valued at US$23.1M. Notable position changes include a 97% trim in Q2 2025 (shares rose 80% over the following quarter), a 332% increase in Q3 2025 (shares rose 17% over the following quarter), a 227% increase in Q4 2025 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 15.96M | $17.40M | New |
| Q4 2023 | 16.92M | $14.18M | Add |
| Q1 2024 | 16.92M | $23.51M | Hold |
| Q2 2024 | 16.92M | $9.81M | Hold |
| Q3 2024 | 16.92M | $11.32M | Hold |
| Q4 2024 | 16.92M | $12.41M | Hold |
| Q1 2025 | 16.92M | $4.00M | Hold |
| Q2 2025 | 563.86K | $1.07M | Reduce |
| Q3 2025 | 2.44M | $8.33M | Add |
| Q4 2025 | 7.97M | $31.87M | Add |
| Q1 2026 | 7.97M | $32.91M | Hold |
| Q2 2026 | 7.97M | $37.21M | Hold |
| Q3 2026 | 7.97M | $23.11M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About XFOR and 13F data
XFOR (X4 PHARMACEUTICALS INC) is a Health Care company. 36 other funds we track also report a position in XFOR — the largest reported positions include PERCEPTIVE ADVISORS LLC (US$37.0M), Empery Asset Management, LP (US$28.2M), Saturn V Capital Management LP (US$21.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding XFOR
- PERCEPTIVE ADVISORS LLC 7.93M sh · $37.05M · Q2 2026
- Empery Asset Management, LP 9.73M sh · $28.20M · Q3 2026
- Saturn V Capital Management LP 7.37M sh · $21.36M · Q3 2026
- NEA Management Company, LLC 3.23M sh · $15.10M · Q2 2026
- Kalehua Capital Management LLC 3.72M sh · $10.80M · Q3 2026
- BVF INC/IL 2.23M sh · $10.43M · Q2 2026
- Rosalind Advisors, Inc. 3.21M sh · $9.32M · Q3 2026
- Venrock Adviser, LLC 1.93M sh · $9.03M · Q2 2026
- Trails Edge Capital Partners, LP 2.57M sh · $7.46M · Q3 2026
- Samsara BioCapital, LLC 1.40M sh · $6.52M · Q2 2026
- Verdad Advisers, LP 323.17K sh · $937.18K · Q3 2026
More on Bain Capital Life Sciences Investors, LLC
FAQ
How long has Bain Capital Life Sciences Investors, LLC held XFOR?
Bain Capital Life Sciences Investors, LLC has disclosed XFOR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Bain Capital Life Sciences Investors, LLC's current position in XFOR?
As of Q3 2026, Bain Capital Life Sciences Investors, LLC holds 7.97M shares of XFOR (X4 PHARMACEUTICALS INC), valued at $23.11M, representing 1.59% of its reported portfolio and ranking #15.
Has Bain Capital Life Sciences Investors, LLC been buying or selling XFOR?
In the latest 13F filing (Q3 2026), Bain Capital Life Sciences Investors, LLC held unchanged its position in XFOR. The position peaked in Q2 2026 at 7.97M shares.
Which other funds hold XFOR?
Other major institutional holders of XFOR include PERCEPTIVE ADVISORS LLC, Empery Asset Management, LP, Saturn V Capital Management LP, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.